These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 3533526)

  • 1. Genetic and physiological modulation of anthracycline-induced mutagenesis in Salmonella typhimurium.
    Cebula TA
    Environ Mutagen; 1986; 8(5):675-92. PubMed ID: 3533526
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Genotoxic and mutagenic activity of antineoplastic anthracyclines and their aglycones: study in two test-systems].
    Vasil'eva SV; Makhova EV; Efremenkova OV; Bartoshevich IuE
    Genetika; 1996 Feb; 32(2):233-9. PubMed ID: 8713623
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Impact of a point mutation in the muc region of plasmid pKM101 on anthracycline-induced mutagenesis in Salmonella typhimurium.
    Cole JA; Thomas HF
    Environ Mutagen; 1985; 7(1):129-33. PubMed ID: 3881252
    [No Abstract]   [Full Text] [Related]  

  • 4. Structure-activity relationship of anthracycline-induced genotoxicity in vitro.
    Westendorf J; Marquardt H; Marquardt H
    Cancer Res; 1984 Dec; 44(12 Pt 1):5599-604. PubMed ID: 6388827
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Plasmid pKM101 muc(-)- and muc(+)-mediated anthracycline mutagenicity and cytotoxicity in Salmonella typhimurium.
    Thomas HF; Cole JA; Freeman B
    Environ Mutagen; 1987; 9(4):369-91. PubMed ID: 3556156
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Mutagenicity of eight anthracycline derivatives in five strains of Salmonella typhimurium.
    Marzin D; Jasmin C; Maral R; Mathe G
    Eur J Cancer Clin Oncol; 1983 May; 19(5):641-7. PubMed ID: 6347692
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Mutagenicity of aclacinomycin A and daunomycin derivatives.
    Umezawa K; Sawamura M; Matsushima T; Sugimura T
    Cancer Res; 1978 Jun; 38(6):1782-4. PubMed ID: 348304
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Preliminary evaluation of treatment and selection conditions which affect expression of anthracycline mutagenicity in Salmonella typhimurium and a diploid human lymphoblast cell line.
    Thomas HF
    J Appl Toxicol; 1987 Dec; 7(6):403-10. PubMed ID: 3323285
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Mutagenicity of anthracycline glycosides and bleomycins in Salmonella assay system.
    Umezawa K; Haresaku M; Muramatsu M; Matsushima T
    Biomed Pharmacother; 1987; 41(5):214-8. PubMed ID: 2444280
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of excision repair and plasmid pKM101 on mutagenic and cytotoxic potencies of anthracycline derivatives in test strains of Salmonella typhimurium.
    Thomas HF; Cole JA
    Environ Mutagen; 1986; 8(6):797-815. PubMed ID: 3536470
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mutagenic and cytotoxic potencies of a series of anthracycline derivatives as measured by His+ reversion, 8-azaguanine resistance and direct plating cytotoxicity tests in Salmonella typhimurium.
    Thomas HF
    Teratog Carcinog Mutagen; 1986; 6(3):219-35. PubMed ID: 2875534
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A new anthracycline with potent antileukemic activity exhibits reduced mutagenicity.
    Andrivon W; Callais F; Nafziger J; Monneret C; Guillosson JJ
    Mutat Res; 1995 Oct; 344(3-4):135-40. PubMed ID: 7491131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Tumorigenicity in vivo and induction of mutagenesis and DNA repair in vitro by aclacinomycin A and marcellomycin: structure-activity relationship and predictive value of short-term tests.
    Westendorf J; Marquardt H; Ketkar MB; Mohr U; Marquardt H
    Cancer Res; 1983 Nov; 43(11):5248-51. PubMed ID: 6352017
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluation of mutagenic and genotoxic activities of new derivatives of anthracyclines.
    Chłopkiewicz B; Ejchart A; Marczewska J; Anuszewska E; Priebe W
    Acta Pol Pharm; 2005; 62(2):99-104. PubMed ID: 16161349
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative genotoxicity of adriamycin and menogarol, two anthracycline antitumor agents.
    Bhuyan BK; Zimmer DM; Mazurek JH; Trzos RJ; Harbach PR; Shu VS; Johnson MA
    Cancer Res; 1983 Nov; 43(11):5293-7. PubMed ID: 6225515
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Effect of excision repair system on antibacterial and mutagenic activity of daunomycin and other intercalating agents in Salmonella typhimurium.
    Pani B; Monti-Bragadin C; Samer L
    Experientia; 1975 Jul; 31(7):787-8. PubMed ID: 1095395
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characteristics of mutagenesis by bleomycin and adriamycin in salmonella typhimurium: action of superoxide dismutase.
    Ejchart A; Marczewska J; Chłopkiewicz B
    Acta Pol Pharm; 1996; 53(1):13-7. PubMed ID: 8960280
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [New anthracycline antibiotics and derivatives].
    Tatsuta K
    Gan To Kagaku Ryoho; 1984 Dec; 11(12 Pt 2):2640-52. PubMed ID: 6594977
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Adriamycin and related anthracycline antibiotics.
    Brown JR
    Prog Med Chem; 1978; 15():125-64. PubMed ID: 400611
    [No Abstract]   [Full Text] [Related]  

  • 20. Hydrogen bonding, overlap geometry, and sequence specificity in anthracycline antitumor antibiotic.DNA complexes in solution.
    Patel DJ; Kozlowski SA; Rice JA
    Proc Natl Acad Sci U S A; 1981 Jun; 78(6):3333-7. PubMed ID: 6267584
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.